Diagnostic Performance of Superb Microvascular Imaging for Breast Masses: A Systematic Review and Meta-analysis

doi:10.37015/AUDT.2022.210028

Abstract

Abstract:

Objective: In the present study, we aimed to evaluate the diagnostic performance of superb microvascular imaging (SMI) for breast masses through a meta-analysis.

Methods: PubMed, EMBASE, Cochrane Library, and Web of Science Core Collection databases, as well as the most comprehensive Chinese academic databases in medicine, such as China Biology Medicine Disc, China National Knowledge Infrastructure, and Wanfang Database, were systematically searched. All included studies used histopathological results as the reference standard. To assess the diagnostic performance, we calculated the pooled sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-), diagnostic odds ratio (DOR), and the area under the curve (AUC). In addition, a subgroup meta-regression analysis was performed to investigate the heterogeneity.

Results: Fourteen of 1,075 identified articles were included in the current review. The pooled sensitivity, specificity, LR+, LR-, and DOR for SMI were 0.85 (95% CI: 0.79-0.89), 0.80 (95% CI: 0.71-0.87), 4.3 (95% CI: 2.9-6.2), 0.19 (95% CI 0.14-0.26), and 22 (95% CI: 14-36), respectively. The AUC was 0.90 (0.87 - 0.92). Meta-regression showed that there were heterogeneities for sensitivity, but not for specificity.

Conclusions: SMI had good sensitivity, specificity, and excellent diagnostic value in distinguishing benign breast masses from malignant masses and could potentially help select suspicious breast masses for surgery.

Key words: Breast; Superb microvascular imaging; Diagnosis; Meta-analysis

Zehui Fu, MD, Siqi Wang, MD, Jian Zhang, MD, Yejun Lu, MD, Xiaomin Mo, MD, Ye He, MD, Chong Wang, MD, Hui Chen, MD. Diagnostic Performance of Superb Microvascular Imaging for Breast Masses: A Systematic Review and Meta-analysis. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(3): 95-103.

References

[1]	Koren S, Bentires-Alj M. Breast tumor heterogeneity: source of fitness, hurdle for therapy. Mol Cell 2015; 60: 537-546.
[2]	Tirona MT, Sehgal R, Ballester O. Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools. Cancer Invest 2010; 28: 743-750.
[3]	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108.
[4]	Li Q, Hu M, Chen Z, Li C, Zhang X, Song Y, et al. Meta-analysis: contrast-enhanced ultrasound versus conventional ultrasound for differentiation of benign and malignant breast lesions. Ultrasound Med Biol 2018; 44: 919-929.
[5]	Corsetti V, Houssami N, Ferrari A, Ghirardi M, Bellarosa S, Angelini O, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer 2008; 44: 539-544.
[6]	Zhu YC, Zu DM, Zhang Y, Shan J, Shi XR, Deng SH, et al. A comparative study on superb microvascular imaging and conventional ultrasonography in differentiating BI-RADS 4 breast lesions. Oncol Lett 2019; 18: 3202-3210.
[7]	Zhu YC, Zhang Y, Deng SH, Jiang Q. Diagnostic performance of superb microvascular imaging (smi) combined with shear-wave elastography in evaluating breast lesions. Med Sci Monit 2018; 24: 5935-5942.
[8]	Lee DH, Lee JY, Han JK. Superb microvascular imaging technology for ultrasound examinations: Initial experiences for hepatic tumors. European Journal of Radiology 2016; 85: 2090-2095.
[9]	Yongfeng Z, Ping Z, Hong P, Wengang L, Yan Z. Superb microvascular imaging compared with contrast-enhanced ultrasound to assess microvessels in thyroid nodules. J Med Ultrason (2001) 2020; 47: 287-297.
[10]	D'Onofrio M, Crosara S, De Robertis R, Canestrini S, Mucelli RP. Contrast-enhanced ultrasound of focal liver lesions. AJR Am J Roentgenol 2015; 205: W56-W66.
[11]	Shibata Y, Fujimoto T, Ohno Y. A new era in diagnostic ultrasound, superb microvascular imaging: preliminary results in pediatric hepato-gastrointestinal disorders. Eur J Pediatr Surg 2016; 27: 20-25.
[12]	Ma Y, Li G, Li J, Ren WD. The Diagnostic value of superb microvascular imaging (SMI) in detecting blood flow signals of breast lesions: a preliminary study comparing smi to color doppler flow imaging. Medicine (Baltimore) 2015; 94: e1502.
[13]	Park AY, Seo BK, Cha SH, Yeom SK, Lee SW, Chung HH. An innovative ultrasound technique for evaluation of tumor vascularity in breast cancers: superb micro-vascular imaging. J Breast Cancer 2016; 19: 210-213.
[14]	Liang M, Ou B, Wu J, Xiao X, Ruan J, Tian J, et al. Combined use of strain elastography and superb microvascular imaging with grayscale ultrasound according to the BI-RADS classification for differentiating benign from malignant solid breast masses. Clin Hemorheol Microcirc 2020; 74: 391-403.
[15]	Chen L, Zhan J, Diao XH, Liu YC, Shi YX, Chen Y, et al. Additional value of superb microvascular imaging for thyroid nodule classification with the thyroid imaging reporting and data system. Ultrasound Med Biol 2019; 45: 2040-2048.
[16]	Cappelli C, Pirola I, Gandossi E, Marini F, Cristiano A, Casella C, et al. Ultrasound microvascular blood flow evaluation: a new tool for the management of thyroid nodule? Int J Endocrinol 2019; 2019:1-6.
[17]	Zu DM, Feng LL, Zhang L, Ma SL, Zhu YC. Evaluation of mesenteric lymph nodes in a pediatric population with mesenteric lymphadenitis using superb microvascular imaging. Med Sci Monit 2019; 25: 5336-5342.
[18]	Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8:336-341.
[19]	Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011 ; 155:529-536.
[20]	Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
[21]	Vamvakas EC. Meta-analyses of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods. Arch Pathol Lab Med 1998; 122: 675-686.
[22]	Chappell FM, Raab GM, Wardlaw JM. When are summary ROC curves appropriate for diagnostic meta-analyses? Stat Med 2009; 28: 2653-2668.
[23]	Adler DD, Carson PL, Rubin JM, Quinn-Reid D. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol 1990; 16: 553-559.
[24]	Kim ES, Seo BK, Park EK, Woo OH, Jung K, Cho KR, et al. Significance of microvascular evaluation of ductal lesions on breast ultrasonography: Influence on diagnostic performance. Clin Imaging 2018; 51: 252-259.
[25]	Xiao XY, Chen X, Guan XF, Wu H, Qin W, Luo BM. Superb microvascular imaging in diagnosis of breast lesions: a comparative study with contrast-enhanced ultrasonographic microvascular imaging. Br J Radiol 2016; 89: 20160546.
[26]	Zhan J, Diao XH, Jin JM, Chen L, Chen Y. Superb microvascular imaging-a new vascular detecting ultrasonographic technique for avascular breast masses: a preliminary study. Eur J Radiol 2016; 85: 915-921.
[27]	Park AY, Seo BK, Woo OH, Jung KS, Cho KR, Park EK, et al. The utility of ultrasound superb microvascular imaging for evaluation of breast tumour vascularity: comparison with colour and power doppler imaging regarding diagnostic performance. Clin Radiol 2018; 73: 304-311.
[28]	Cai SM, Wang HY, Zhang XY, Zhang L, Zhu QL, Li JC, et al. The vascular index of superb microvascular imaging can improve the diagnostic accuracy for breast imaging reporting and data system category 4 breast lesions. Cancer Manag Res 2020; 12: 1819-1826.
[29]	Zhang XY, Zhang L, Li N, Zhu QL, Li JC, Sun Q, et al. Vascular index measured by smart 3-D superb microvascular imaging can help to differentiate malignant and benign breast lesion. Cancer Manag Res 2019; 11: 5481-5487.
[30]	Jian Z, Hui C, Bin X, Xie G, Chong W, Yejun L, et al. Study on the diagnostic value of superb microvascular imaging, advanced dynamic flow and color Doppler flow imaging in breast microcarcinoma and their correlation with pathological microvessel density. Chin J Ultrasonogr 2019; 28:787-793.
[31]	Lu X, Wen C, Hua W. Preliminary analysis of diagnostic efficiency of vascular morphology distribution in breast tumor by superb microvascular imaging. Chin J Ultrasonogr 2018; 27: 973-976.
[32]	Mao-yi L, Qin-yin L, Chen C, Xu-xiang L, Luo-ping Q, Ji-xi L, et al. Application value of superb microvascular imaging technique in qualitative diagnosis of breast masses with breast imaging reporting and data system category 4. Guangxi Medical Journal 2019; 41: 1902-1905.
[33]	Xin C, Baoming L, Xiaofeng G, Huan W, Xiaoyun X. Comparative study of superb microvascular imaging and contrast-enhanced ultrasonographic microvascular imaging in diagnosis of breast tumor. Chin J Ultrasonogr 2016; 25: 608-611.
[34]	Yan MA, Gang LI, Jing LI, Wei-dong R. Superb microvascular imaging for detecting blood flow of breast neoplasms. Chin J Med Imaging Technol 2015; 31: 659-662.
[35]	Xiang LI, Shu K, Xue-mei W, Yin-yan LI, Zhi-ying F, Jian-nan W. Application of superb microvascular imaging and CDFI in diagnosis of breast masses. Chin J Med Imaging Technol 2015; 31:663-667.
[36]	Liu W, Li W, Li Z, Shi L, Zhao P, Guo Z, et al. Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma. Breast Cancer Res Treat 2020; 181:127-134.
[37]	Xiang H, Tang G, Li Y, Liu Y, Liu L, Lin X. Value of hand-held ultrasound in the differential diagnosis and accurate breast imaging reporting and data system subclassification of complex cystic and solid breast lesions. Ultrasound in Medicine & Biology 2020; 46:1111-1118.
[38]	Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
[39]	Shen ZY, Hu B, Wu MF. Correlation between blood flow signal of color flow imaging and nottingham prognostic index in patients with breast carcinoma. Breast Care (Basel) 2012; 7:126-130.
[40]	Jiang ZZ, Huang YH, Shen HL, Liu XT. Clinical applications of superb microvascular imaging in the liver, breast, thyroid, skeletal muscle, and carotid plaques. J Ultrasound Med 2019; 38: 2811-2820.
[41]	Liu W, Zhou P, Zhao Y, Tian S, Wu X. Superb microvascular imaging compared with contrast-enhanced ultrasound for assessing laser ablation treatment of benign thyroid nodules. Biomed Res Int 2018; 2018:1025657.
[42]	Ayaz E, Aslan A, Inan I, Yikilmaz A. Evaluation of ovarian vascularity in children by using the "superb microvascular imaging" ultrasound technique in comparison with conventional doppler ultrasound techniques. J Ultrasound Med 2019; 38:2751-2760.
[43]	Cronin P, Dwamena BA, Kelly AM, Bernstein SJ, Carlos RC. Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests. Eur Radiol 2008; 18:1840-1856.